Global Single-target MET TKIs Market Growth 2026-2032

February 2026 | 101 pages | ID: G02F8FCA5AA4EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Single-target MET TKIs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Single-target MET tyrosine kinase inhibitors (TKIs) are drugs specifically designed to block the activity of the MET receptor tyrosine kinase alone, focusing on disrupting the MET signaling pathway that promotes cancer cell growth, survival, and metastasis.

United States market for Single-target MET TKIs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Single-target MET TKIs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Single-target MET TKIs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Single-target MET TKIs players cover Novartis, Merck, WuXi STA, Shanghai Hutchison Pharmaceuticals, Haihe Biopharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Single-target MET TKIs Industry Forecast” looks at past sales and reviews total world Single-target MET TKIs sales in 2025, providing a comprehensive analysis by region and market sector of projected Single-target MET TKIs sales for 2026 through 2032. With Single-target MET TKIs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Single-target MET TKIs industry.

This Insight Report provides a comprehensive analysis of the global Single-target MET TKIs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Single-target MET TKIs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Single-target MET TKIs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Single-target MET TKIs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Single-target MET TKIs.

This report presents a comprehensive overview, market shares, and growth opportunities of Single-target MET TKIs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Capmatinib
  • Tepotinib
  • Savolitinib
  • Glumetinib
  • Vebreltinib
  • Other
Segmentation by Application:
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Novartis
  • Merck
  • WuXi STA
  • Shanghai Hutchison Pharmaceuticals
  • Haihe Biopharma
  • CSPC Pharmaceutical
  • Avistone Pharmaceuticals Biotechnology
  • Asymchem
Key Questions Addressed in this Report

What is the 10-year outlook for the global Single-target MET TKIs market?

What factors are driving Single-target MET TKIs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Single-target MET TKIs market opportunities vary by end market size?

How does Single-target MET TKIs break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Single-target MET TKIs Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Single-target MET TKIs by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Single-target MET TKIs by Country/Region, 2021, 2025 & 2032
2.2 Single-target MET TKIs Segment by Type
  2.2.1 Capmatinib
  2.2.2 Tepotinib
  2.2.3 Savolitinib
  2.2.4 Glumetinib
  2.2.5 Vebreltinib
  2.2.6 Other
  2.2.7 Single-target MET TKIs Sales by Type
    2.2.7.1 Global Single-target MET TKIs Sales Market Share by Type (2021-2026)
    2.2.7.2 Global Single-target MET TKIs Revenue and Market Share by Type (2021-2026)
    2.2.7.3 Global Single-target MET TKIs Sale Price by Type (2021-2026)
2.3 Single-target MET TKIs Segment by Application
  2.3.1 Hospital and Clinic
  2.3.2 Retail Pharmacies
  2.3.3 Other
  2.3.4 Single-target MET TKIs Sales by Application
    2.3.4.1 Global Single-target MET TKIs Sale Market Share by Application (2021-2026)
    2.3.4.2 Global Single-target MET TKIs Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global Single-target MET TKIs Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Single-target MET TKIs Breakdown Data by Company
  3.1.1 Global Single-target MET TKIs Annual Sales by Company (2021-2026)
  3.1.2 Global Single-target MET TKIs Sales Market Share by Company (2021-2026)
3.2 Global Single-target MET TKIs Annual Revenue by Company (2021-2026)
  3.2.1 Global Single-target MET TKIs Revenue by Company (2021-2026)
  3.2.2 Global Single-target MET TKIs Revenue Market Share by Company (2021-2026)
3.3 Global Single-target MET TKIs Sale Price by Company
3.4 Key Manufacturers Single-target MET TKIs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Single-target MET TKIs Product Location Distribution
  3.4.2 Players Single-target MET TKIs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR SINGLE-TARGET MET TKIS BY GEOGRAPHIC REGION

4.1 World Historic Single-target MET TKIs Market Size by Geographic Region (2021-2026)
  4.1.1 Global Single-target MET TKIs Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Single-target MET TKIs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Single-target MET TKIs Market Size by Country/Region (2021-2026)
  4.2.1 Global Single-target MET TKIs Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Single-target MET TKIs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Single-target MET TKIs Sales Growth
4.4 APAC Single-target MET TKIs Sales Growth
4.5 Europe Single-target MET TKIs Sales Growth
4.6 Middle East & Africa Single-target MET TKIs Sales Growth

5 AMERICAS

5.1 Americas Single-target MET TKIs Sales by Country
  5.1.1 Americas Single-target MET TKIs Sales by Country (2021-2026)
  5.1.2 Americas Single-target MET TKIs Revenue by Country (2021-2026)
5.2 Americas Single-target MET TKIs Sales by Type (2021-2026)
5.3 Americas Single-target MET TKIs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Single-target MET TKIs Sales by Region
  6.1.1 APAC Single-target MET TKIs Sales by Region (2021-2026)
  6.1.2 APAC Single-target MET TKIs Revenue by Region (2021-2026)
6.2 APAC Single-target MET TKIs Sales by Type (2021-2026)
6.3 APAC Single-target MET TKIs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Single-target MET TKIs by Country
  7.1.1 Europe Single-target MET TKIs Sales by Country (2021-2026)
  7.1.2 Europe Single-target MET TKIs Revenue by Country (2021-2026)
7.2 Europe Single-target MET TKIs Sales by Type (2021-2026)
7.3 Europe Single-target MET TKIs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Single-target MET TKIs by Country
  8.1.1 Middle East & Africa Single-target MET TKIs Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Single-target MET TKIs Revenue by Country (2021-2026)
8.2 Middle East & Africa Single-target MET TKIs Sales by Type (2021-2026)
8.3 Middle East & Africa Single-target MET TKIs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Single-target MET TKIs
10.3 Manufacturing Process Analysis of Single-target MET TKIs
10.4 Industry Chain Structure of Single-target MET TKIs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Single-target MET TKIs Distributors
11.3 Single-target MET TKIs Customer

12 WORLD FORECAST REVIEW FOR SINGLE-TARGET MET TKIS BY GEOGRAPHIC REGION

12.1 Global Single-target MET TKIs Market Size Forecast by Region
  12.1.1 Global Single-target MET TKIs Forecast by Region (2027-2032)
  12.1.2 Global Single-target MET TKIs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Single-target MET TKIs Forecast by Type (2027-2032)
12.7 Global Single-target MET TKIs Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Novartis
  13.1.1 Novartis Company Information
  13.1.2 Novartis Single-target MET TKIs Product Portfolios and Specifications
  13.1.3 Novartis Single-target MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Novartis Main Business Overview
  13.1.5 Novartis Latest Developments
13.2 Merck
  13.2.1 Merck Company Information
  13.2.2 Merck Single-target MET TKIs Product Portfolios and Specifications
  13.2.3 Merck Single-target MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Merck Main Business Overview
  13.2.5 Merck Latest Developments
13.3 WuXi STA
  13.3.1 WuXi STA Company Information
  13.3.2 WuXi STA Single-target MET TKIs Product Portfolios and Specifications
  13.3.3 WuXi STA Single-target MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 WuXi STA Main Business Overview
  13.3.5 WuXi STA Latest Developments
13.4 Shanghai Hutchison Pharmaceuticals
  13.4.1 Shanghai Hutchison Pharmaceuticals Company Information
  13.4.2 Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Product Portfolios and Specifications
  13.4.3 Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Shanghai Hutchison Pharmaceuticals Main Business Overview
  13.4.5 Shanghai Hutchison Pharmaceuticals Latest Developments
13.5 Haihe Biopharma
  13.5.1 Haihe Biopharma Company Information
  13.5.2 Haihe Biopharma Single-target MET TKIs Product Portfolios and Specifications
  13.5.3 Haihe Biopharma Single-target MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Haihe Biopharma Main Business Overview
  13.5.5 Haihe Biopharma Latest Developments
13.6 CSPC Pharmaceutical
  13.6.1 CSPC Pharmaceutical Company Information
  13.6.2 CSPC Pharmaceutical Single-target MET TKIs Product Portfolios and Specifications
  13.6.3 CSPC Pharmaceutical Single-target MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 CSPC Pharmaceutical Main Business Overview
  13.6.5 CSPC Pharmaceutical Latest Developments
13.7 Avistone Pharmaceuticals Biotechnology
  13.7.1 Avistone Pharmaceuticals Biotechnology Company Information
  13.7.2 Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Product Portfolios and Specifications
  13.7.3 Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Avistone Pharmaceuticals Biotechnology Main Business Overview
  13.7.5 Avistone Pharmaceuticals Biotechnology Latest Developments
13.8 Asymchem
  13.8.1 Asymchem Company Information
  13.8.2 Asymchem Single-target MET TKIs Product Portfolios and Specifications
  13.8.3 Asymchem Single-target MET TKIs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Asymchem Main Business Overview
  13.8.5 Asymchem Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Single-target MET TKIs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Single-target MET TKIs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Capmatinib
Table 4. Major Players of Tepotinib
Table 5. Major Players of Savolitinib
Table 6. Major Players of Glumetinib
Table 7. Major Players of Vebreltinib
Table 8. Major Players of Other
Table 9. Global Single-target MET TKIs Sales by Type (2021-2026) & (K Units)
Table 10. Global Single-target MET TKIs Sales Market Share by Type (2021-2026)
Table 11. Global Single-target MET TKIs Revenue by Type (2021-2026) & ($ million)
Table 12. Global Single-target MET TKIs Revenue Market Share by Type (2021-2026)
Table 13. Global Single-target MET TKIs Sale Price by Type (2021-2026) & (US$/Unit)
Table 14. Global Single-target MET TKIs Sale by Application (2021-2026) & (K Units)
Table 15. Global Single-target MET TKIs Sale Market Share by Application (2021-2026)
Table 16. Global Single-target MET TKIs Revenue by Application (2021-2026) & ($ million)
Table 17. Global Single-target MET TKIs Revenue Market Share by Application (2021-2026)
Table 18. Global Single-target MET TKIs Sale Price by Application (2021-2026) & (US$/Unit)
Table 19. Global Single-target MET TKIs Sales by Company (2021-2026) & (K Units)
Table 20. Global Single-target MET TKIs Sales Market Share by Company (2021-2026)
Table 21. Global Single-target MET TKIs Revenue by Company (2021-2026) & ($ millions)
Table 22. Global Single-target MET TKIs Revenue Market Share by Company (2021-2026)
Table 23. Global Single-target MET TKIs Sale Price by Company (2021-2026) & (US$/Unit)
Table 24. Key Manufacturers Single-target MET TKIs Producing Area Distribution and Sales Area
Table 25. Players Single-target MET TKIs Products Offered
Table 26. Single-target MET TKIs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Single-target MET TKIs Sales by Geographic Region (2021-2026) & (K Units)
Table 30. Global Single-target MET TKIs Sales Market Share Geographic Region (2021-2026)
Table 31. Global Single-target MET TKIs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 32. Global Single-target MET TKIs Revenue Market Share by Geographic Region (2021-2026)
Table 33. Global Single-target MET TKIs Sales by Country/Region (2021-2026) & (K Units)
Table 34. Global Single-target MET TKIs Sales Market Share by Country/Region (2021-2026)
Table 35. Global Single-target MET TKIs Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Single-target MET TKIs Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Single-target MET TKIs Sales by Country (2021-2026) & (K Units)
Table 38. Americas Single-target MET TKIs Sales Market Share by Country (2021-2026)
Table 39. Americas Single-target MET TKIs Revenue by Country (2021-2026) & ($ millions)
Table 40. Americas Single-target MET TKIs Sales by Type (2021-2026) & (K Units)
Table 41. Americas Single-target MET TKIs Sales by Application (2021-2026) & (K Units)
Table 42. APAC Single-target MET TKIs Sales by Region (2021-2026) & (K Units)
Table 43. APAC Single-target MET TKIs Sales Market Share by Region (2021-2026)
Table 44. APAC Single-target MET TKIs Revenue by Region (2021-2026) & ($ millions)
Table 45. APAC Single-target MET TKIs Sales by Type (2021-2026) & (K Units)
Table 46. APAC Single-target MET TKIs Sales by Application (2021-2026) & (K Units)
Table 47. Europe Single-target MET TKIs Sales by Country (2021-2026) & (K Units)
Table 48. Europe Single-target MET TKIs Revenue by Country (2021-2026) & ($ millions)
Table 49. Europe Single-target MET TKIs Sales by Type (2021-2026) & (K Units)
Table 50. Europe Single-target MET TKIs Sales by Application (2021-2026) & (K Units)
Table 51. Middle East & Africa Single-target MET TKIs Sales by Country (2021-2026) & (K Units)
Table 52. Middle East & Africa Single-target MET TKIs Revenue Market Share by Country (2021-2026)
Table 53. Middle East & Africa Single-target MET TKIs Sales by Type (2021-2026) & (K Units)
Table 54. Middle East & Africa Single-target MET TKIs Sales by Application (2021-2026) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Single-target MET TKIs
Table 56. Key Market Challenges & Risks of Single-target MET TKIs
Table 57. Key Industry Trends of Single-target MET TKIs
Table 58. Single-target MET TKIs Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Single-target MET TKIs Distributors List
Table 61. Single-target MET TKIs Customer List
Table 62. Global Single-target MET TKIs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. Global Single-target MET TKIs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Americas Single-target MET TKIs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Americas Single-target MET TKIs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. APAC Single-target MET TKIs Sales Forecast by Region (2027-2032) & (K Units)
Table 67. APAC Single-target MET TKIs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Europe Single-target MET TKIs Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Europe Single-target MET TKIs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Middle East & Africa Single-target MET TKIs Sales Forecast by Country (2027-2032) & (K Units)
Table 71. Middle East & Africa Single-target MET TKIs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. Global Single-target MET TKIs Sales Forecast by Type (2027-2032) & (K Units)
Table 73. Global Single-target MET TKIs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 74. Global Single-target MET TKIs Sales Forecast by Application (2027-2032) & (K Units)
Table 75. Global Single-target MET TKIs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 76. Novartis Basic Information, Single-target MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 77. Novartis Single-target MET TKIs Product Portfolios and Specifications
Table 78. Novartis Single-target MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 79. Novartis Main Business
Table 80. Novartis Latest Developments
Table 81. Merck Basic Information, Single-target MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 82. Merck Single-target MET TKIs Product Portfolios and Specifications
Table 83. Merck Single-target MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. Merck Main Business
Table 85. Merck Latest Developments
Table 86. WuXi STA Basic Information, Single-target MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 87. WuXi STA Single-target MET TKIs Product Portfolios and Specifications
Table 88. WuXi STA Single-target MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. WuXi STA Main Business
Table 90. WuXi STA Latest Developments
Table 91. Shanghai Hutchison Pharmaceuticals Basic Information, Single-target MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 92. Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Product Portfolios and Specifications
Table 93. Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Shanghai Hutchison Pharmaceuticals Main Business
Table 95. Shanghai Hutchison Pharmaceuticals Latest Developments
Table 96. Haihe Biopharma Basic Information, Single-target MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 97. Haihe Biopharma Single-target MET TKIs Product Portfolios and Specifications
Table 98. Haihe Biopharma Single-target MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Haihe Biopharma Main Business
Table 100. Haihe Biopharma Latest Developments
Table 101. CSPC Pharmaceutical Basic Information, Single-target MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 102. CSPC Pharmaceutical Single-target MET TKIs Product Portfolios and Specifications
Table 103. CSPC Pharmaceutical Single-target MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. CSPC Pharmaceutical Main Business
Table 105. CSPC Pharmaceutical Latest Developments
Table 106. Avistone Pharmaceuticals Biotechnology Basic Information, Single-target MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 107. Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Product Portfolios and Specifications
Table 108. Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Avistone Pharmaceuticals Biotechnology Main Business
Table 110. Avistone Pharmaceuticals Biotechnology Latest Developments
Table 111. Asymchem Basic Information, Single-target MET TKIs Manufacturing Base, Sales Area and Its Competitors
Table 112. Asymchem Single-target MET TKIs Product Portfolios and Specifications
Table 113. Asymchem Single-target MET TKIs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Asymchem Main Business
Table 115. Asymchem Latest Developments

LIST OF FIGURES

Figure 1. Picture of Single-target MET TKIs
Figure 2. Single-target MET TKIs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Single-target MET TKIs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Single-target MET TKIs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Single-target MET TKIs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Single-target MET TKIs Sales Market Share by Country/Region (2025)
Figure 10. Single-target MET TKIs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Capmatinib
Figure 12. Product Picture of Tepotinib
Figure 13. Product Picture of Savolitinib
Figure 14. Product Picture of Glumetinib
Figure 15. Product Picture of Vebreltinib
Figure 16. Product Picture of Other
Figure 17. Global Single-target MET TKIs Sales Market Share by Type in 2026
Figure 18. Global Single-target MET TKIs Revenue Market Share by Type (2021-2026)
Figure 19. Single-target MET TKIs Consumed in Hospital and Clinic
Figure 20. Global Single-target MET TKIs Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 21. Single-target MET TKIs Consumed in Retail Pharmacies
Figure 22. Global Single-target MET TKIs Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 23. Single-target MET TKIs Consumed in Other
Figure 24. Global Single-target MET TKIs Market: Other (2021-2026) & (K Units)
Figure 25. Global Single-target MET TKIs Sale Market Share by Application (2025)
Figure 26. Global Single-target MET TKIs Revenue Market Share by Application in 2026
Figure 27. Single-target MET TKIs Sales by Company in 2026 (K Units)
Figure 28. Global Single-target MET TKIs Sales Market Share by Company in 2026
Figure 29. Single-target MET TKIs Revenue by Company in 2026 ($ millions)
Figure 30. Global Single-target MET TKIs Revenue Market Share by Company in 2026
Figure 31. Global Single-target MET TKIs Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Single-target MET TKIs Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Single-target MET TKIs Sales 2021-2026 (K Units)
Figure 34. Americas Single-target MET TKIs Revenue 2021-2026 ($ millions)
Figure 35. APAC Single-target MET TKIs Sales 2021-2026 (K Units)
Figure 36. APAC Single-target MET TKIs Revenue 2021-2026 ($ millions)
Figure 37. Europe Single-target MET TKIs Sales 2021-2026 (K Units)
Figure 38. Europe Single-target MET TKIs Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Single-target MET TKIs Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa Single-target MET TKIs Revenue 2021-2026 ($ millions)
Figure 41. Americas Single-target MET TKIs Sales Market Share by Country in 2026
Figure 42. Americas Single-target MET TKIs Revenue Market Share by Country (2021-2026)
Figure 43. Americas Single-target MET TKIs Sales Market Share by Type (2021-2026)
Figure 44. Americas Single-target MET TKIs Sales Market Share by Application (2021-2026)
Figure 45. United States Single-target MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Single-target MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Single-target MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Single-target MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Single-target MET TKIs Sales Market Share by Region in 2026
Figure 50. APAC Single-target MET TKIs Revenue Market Share by Region (2021-2026)
Figure 51. APAC Single-target MET TKIs Sales Market Share by Type (2021-2026)
Figure 52. APAC Single-target MET TKIs Sales Market Share by Application (2021-2026)
Figure 53. China Single-target MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Single-target MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Single-target MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Single-target MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 57. India Single-target MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Single-target MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Single-target MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Single-target MET TKIs Sales Market Share by Country in 2026
Figure 61. Europe Single-target MET TKIs Revenue Market Share by Country (2021-2026)
Figure 62. Europe Single-target MET TKIs Sales Market Share by Type (2021-2026)
Figure 63. Europe Single-target MET TKIs Sales Market Share by Application (2021-2026)
Figure 64. Germany Single-target MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 65. France Single-target MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Single-target MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Single-target MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Single-target MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Single-target MET TKIs Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Single-target MET TKIs Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Single-target MET TKIs Sales Market Share by Application (2021-2026)
Figure 72. Egypt Single-target MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Single-target MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Single-target MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Single-target MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Single-target MET TKIs Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Single-target MET TKIs in 2026
Figure 78. Manufacturing Process Analysis of Single-target MET TKIs
Figure 79. Industry Chain Structure of Single-target MET TKIs
Figure 80. Channels of Distribution
Figure 81. Global Single-target MET TKIs Sales Market Forecast by Region (2027-2032)
Figure 82. Global Single-target MET TKIs Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Single-target MET TKIs Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Single-target MET TKIs Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Single-target MET TKIs Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Single-target MET TKIs Revenue Market Share Forecast by Application (2027-2032)


More Publications